NasdaqGM:LNTHMedical Equipment
Assessing Lantheus Holdings (LNTH) Valuation As New ASCO 2026 Oncology Data Nears Publication
Lantheus Holdings (LNTH) is drawing fresh attention after announcing that new clinical and real world oncology data will be featured at the 2026 American Society of Clinical Oncology Annual Meeting in Chicago.
See our latest analysis for Lantheus Holdings.
The stock has pulled back slightly in the past week, but a 30 day share price return of 22.34% and year to date share price return of 47.61% suggest momentum has been building. The 5 year total shareholder return of over 3x highlights how...